Mobile Menu

Week in Brief: Week Ending 5th September

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from the last seven days.

A genomic test for cardiovascular disease risk is now available for some patients in the US. The test, which combines genomic insights with clinical-grade reporting, can predict the inherited risk of eight conditions, including coronary artery disease and hypertension.

Scientists from across the globe will play a part in ambitious plans to sequence 3,000 genomes per month to better understand the Earth’s biodiversity. This is the second phase of the Earth BioGenome Project, which aims to sequence every one of the 1.67 million known species on our planet by 2035.

New research shows the importance of cognitive assessments for MS patients. In a three-stage observational study, scientists tested the use of an online platform to monitor cognitive deficits in MS. They subsequently identified a subtype of the condition that features significant cognitive impairment but minimal physical symptoms.

The time of day breast milk is expressed could influence infants’ circadian rhythms. A study has shown that the concentration of bioactive components found in stored breast milk varies throughout the day. Aligning feed times with the time that the milk was first expressed could help to regulate biological cycles and maximise the benefit of breast feeding.

A large-scale epigenetic atlas has shed new light on the process of aging. This resource shows how DNA methylation changes over time across 17 different human tissues, providing a clearer understanding of how gene activity shifts with age, leading to the physical changes and increased disease risk we associate with getting older. 

Prolonged use of an injectable contraceptive is associated with an increased risk of non-cancerous brain tumours. Women who used depot medroxyprogesterone acetate for more than four years, or who began using it after the age of 31, were at an increased risk of meningiomas compared to those using other or no contraceptives. 

There is limited association between microbes and some cancers. This is according to a new study that challenges previous publications, which had found extensive links between the microbiome and multiple tumour types. This new analysis of data from The Cancer Genome Atlas shows that many of these associations may in fact have arisen from contamination of sequencing tools.

A gene variant impacting the function of microglia increases the risk of Alzheimer’s disease. A mutation in the PICALM gene impairs the ability of these immune cells to clear ‘debris’ from the brain, contributing to the onset of Alzheimer’s. A better understanding of the impact of this variant could contribute to the development of new therapies.

Genetic ancestry plays a crucial role in the risk of colorectal cancer. A study of the diverse Brazilian population has shown that individuals who have lower proportions of African and Asian ancestry had an increased risk of disease, suggesting the presence of protective genetic variants. The researchers analysed 45 genetic variants, and found nine were associated with the disease. 

Patients with genetic dilated cardiomyopathy are at a higher risk of advanced heart failure. Individuals suffering from this condition and who experience severe arrhythmias are also at risk of requiring a heart transplant, according to a new study of over 1,200 patients. The findings could lead to new opportunities for precision treatments.

Check out last week’s Week in Brief here.